Page last updated: 2024-08-21

triethylenephosphoramide and Breast Cancer

triethylenephosphoramide has been researched along with Breast Cancer in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19904 (44.44)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dang, X; Li, S; Liu, Y; Wu, C; Yang, H; Zhang, J1
Di, L; Lyerly, HK; Ren, J; Shao, H; Song, G; Song, Q; Wang, X; Yang, H; Yu, J; Zhou, X; Zhu, X1
Beijnen, JH; Doodeman, VD; Ekhart, C; Huitema, AD; Rodenhuis, S; Smits, PH1
GRECO, T1
Beijnen, JH; de Jonge, ME; Huitema, AD; Rodenhuis, S; van Dam, SM1
Bero, T; Bolovin, LM; Javor, T; Kaplan, MA; Medvedev, VN; Verchovskaja, NI1
Beijnen, JH; Huitema, AD; Rodenhuis, S; van Maanen, MJ1
Cohen, BE; Egorin, MJ; Gutierrez, PL; Kohlhepp, EA1
Aisner, J; Cohen, BE; Egorin, MJ; Gutierrez, PL; Kohlhepp, EA1

Trials

1 trial(s) available for triethylenephosphoramide and Breast Cancer

ArticleYear
Population pharmacokinetics of cyclophosphamide and its metabolites 4-hydroxycyclophosphamide, 2-dechloroethylcyclophosphamide, and phosphoramide mustard in a high-dose combination with Thiotepa and Carboplatin.
    Therapeutic drug monitoring, 2005, Volume: 27, Issue:6

    Topics: Adolescent; Adult; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Carboplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Neoplasms; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Phosphoramide Mustards; Prodrugs; Thiotepa; Time Factors; Triethylenephosphoramide

2005

Other Studies

8 other study(ies) available for triethylenephosphoramide and Breast Cancer

ArticleYear
Copper depletion inhibits CoCl2-induced aggressive phenotype of MCF-7 cells via downregulation of HIF-1 and inhibition of Snail/Twist-mediated epithelial-mesenchymal transition.
    Scientific reports, 2015, Jul-15, Volume: 5

    Topics: Animals; Antineoplastic Agents, Alkylating; Breast Neoplasms; Cation Transport Proteins; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Polarity; Cobalt; Copper; Copper Transporter 1; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Fibronectins; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; MCF-7 Cells; Mice; Mice, Inbred BALB C; Nuclear Proteins; Phenotype; RNA Interference; RNA, Small Interfering; Signal Transduction; Snail Family Transcription Factors; Transcription Factors; Transcriptional Activation; Transplantation, Heterologous; Triethylenephosphoramide; Twist-Related Protein 1; Vimentin

2015
Transformation of alkylating regimen of thiotepa into tepa determines the disease progression through GSTP1 gene polymorphism for metastatic breast cancer patients receiving thiotepa containing salvage chemotherapy.
    International journal of clinical pharmacology and therapeutics, 2015, Volume: 53, Issue:11

    Topics: Aged; Antineoplastic Agents, Alkylating; Biotransformation; Breast Neoplasms; Chi-Square Distribution; China; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Disease Progression; Disease-Free Survival; Female; Genotype; Glutathione S-Transferase pi; Humans; Logistic Models; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Odds Ratio; Patient Selection; Pharmacogenetics; Phenotype; Polymorphism, Single Nucleotide; Retrospective Studies; Risk Factors; Salvage Therapy; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Thiotepa; Time Factors; Treatment Outcome; Triethylenephosphoramide

2015
Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa.
    British journal of clinical pharmacology, 2009, Volume: 67, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Aryl Hydrocarbon Hydroxylases; Breast Neoplasms; Carboplatin; Chromatography, High Pressure Liquid; Cohort Studies; Cyclophosphamide; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Female; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Male; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Oxidoreductases, N-Demethylating; Polymorphism, Genetic; Thiotepa; Triethylenephosphoramide

2009
[Triethylene-phosphoramide or thio-TEPA in therapy of recurrent cancer of the breast].
    La Presse medicale, 1959, Jan-24, Volume: 67, Issue:4

    Topics: Antineoplastic Agents; Breast; Breast Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasms; Phosphoramides; Thiotepa; Triethylenephosphoramide

1959
[Whole body radiometric study of 59Fe absorption during chemotherapy of breast cancer].
    Radiobiologia, radiotherapia, 1982, Volume: 23, Issue:6

    Topics: Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Iron; Iron Radioisotopes; Middle Aged; Thiotepa; Triethylenephosphoramide

1982
Urinary excretion of thioTEPA and its metabolites in patients treated with high-dose cyclophosphamide, thioTEPA and carboplatin.
    Anti-cancer drugs, 2001, Volume: 12, Issue:6

    Topics: Acetylcysteine; Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Breast Neoplasms; Carboplatin; Creatinine; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Models, Chemical; Neoplasms, Germ Cell and Embryonal; Thiotepa; Time Factors; Triethylenephosphoramide

2001
Gas-liquid chromatographic analysis of N,N',N''-triethylene thiophosphoramide and N,N',N''-triethylene phosphoramide in biological samples.
    Journal of chromatography, 1985, Sep-13, Volume: 343, Issue:1

    Topics: Azirines; Breast Neoplasms; Chromatography, Gas; Female; Humans; Kinetics; Middle Aged; Thiotepa; Triethylenephosphoramide

1985
Human plasma pharmacokinetics and urinary excretion of thiotepa and its metabolites.
    Cancer treatment reports, 1986, Volume: 70, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chromatography, Gas; Half-Life; Humans; Hydrogen-Ion Concentration; Kinetics; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Thiotepa; Triethylenephosphoramide

1986